Loss of maspin is a helpful prognosticator in colorectal cancer: A tissue microarray analysis

Pathology Research and Practice

Volumn 200, Issue 11-12, 2005, Pages 783-790

  Boltze, Carsten ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Colorectal carcinoma; Maspin; Prognosis

Indexed keywords

MASPIN; MUTANT PROTEIN; PROTEIN P53; SERINE PROTEINASE INHIBITOR; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEMICOLECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; SEX DIFFERENCE; SURVIVAL TIME; TISSUE MICROARRAY; TREATMENT PLANNING;

EID: 13544263527     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prp.2004.10.004     Document Type: Article

References (27)

1. W. Aizu K. Guda P. Nambiar T. Xin M. Thibodeau D.W. Rosenberg C. Giardina p53 and its co-activator p300 are inversely regulated in the mouse colon in response to carcinogen Toxicol. Lett. 144 2003 213-224
2. C. Arun N.J. London D.M. Hemingway Prognostic significance of elevated endothelin-1 levels in patients with colorectal cancer Int. J. Biol. Markers 19 2004 32-37
3. B.M. Berger L. Robison J. Glickman Colon cancer-associated DNA mutations: Marker selection for the detection of proximal colon cancer Diagn. Mol. Pathol. 12 2003 187-192
4. C. Boltze R. Schneider-Stock F. Meyer B. Peters C. Quednow C. Hoang-Vu A. Roessner Maspin in thyroid cancer: Its relationship with p53 and clinical outcome Oncol. Rep. 10 2003 1783-1788
5. C. Boltze R. Schneider-Stock C. Quednow R. Gerlach C. Mawrin R. Hinze A. Roessner C. Hoang-Vu Proteome analysis identified Maspin as a special feature of papillary thyroid carcinoma Int. J. Oncol. 23 2003 1323-1328
6. C. Boltze R. Schneider-Stock C. Quednow R. Hinze C. Mawrin A. Hribaschek A. Roessner C. Hoang-Vu Silencing of the maspin gene by promoter hypermethylation in thyroid cancer Int. J. Mol. Med. 11 2003 479-484
7. F.E. Domann J.C. Rice M.J. Hendrix B.W. Futcher Epigenetic silencing of maspin gene expression in human breast cancers Int. J. Cancer 85 2000 805-810
8. A. Emterling A. Wallin G. Arbman X.F. Sun Clinicopathological significance of microsatellite instability and mutated RIZ in colorectal cancer Ann. Oncol. 15 2004 242-246
9. T. Hojo Y. Akiyama K. Nagasaki K. Maruyama K. Kikuchi T. Ikeda M. Katajima K. Yamaguchi Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues Cancer Lett. 171 2001 103-110
10. S. Machtens J. Serth C. Bokemeyer W. Bathke A. Minssen C. Kollmannsberger J. Hartmann R. Knuchel M. Kondo U. Jonas M. Kuczyk Expression of the p53 and maspin protein in primary prostate cancer: correlation with clinical features Int. J. Cancer 95 2001 337-342
11. S.K. Mohsin M. Zhang G.M. Clark D.C. Allred Maspin expression in invasive breast cancer: Association with other prognostic factors J. Pathol. 199 2003 432-435
12. P.A. Pemberton A.R. Tipton N. Pavloff et al. Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface J. Histochem. Cytochem. 45 1997 1697-1706
13. R.S. Saad Y.L. Liu G. Nathan J. Celebrezze D. Medich J.F. Silverman Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer Mod. Pathol. 17 2004 197-203
14. R. Sager Function of maspin Science 165 1994 1893-1894
15. R. Schneider-Stock C. Boltze B. Peters T. Höpfner F. Meyer H. Lippert Differences in loss of p16INK4A protein expression by promoter methylation between left- and right-sided primary colorectal carcinomas Int. J. Oncol. 23 2003 1009-1013
16. S. Sheng J. Carey E.A. Seftor L. Dias M.J. Hendrix R. Sager Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells Proc. Natl. Acad. Sci. USA 93 1996 11669-11674
17. H.Y. Shi W. Zhang R. Liang et al. Blocking tumor growth invasion and metastasis by maspin in a synegeneic breast cancer model Cancer Res. 61 2001 6945-6951
18. S.Y. Song S.K. Lee D.H. Kim H.J. Son H.J. Kim Y.J. Lim W.Y. Lee H.K. Chun J.C. Rhee Expression of maspin in colon cancers: Its relationship with p53 expression and microvessel density Dig. Dis. Sci. 47 2002 1831-1835
19. W. Xia Y.K. Lau M.C. Hu L. Li D.A. Johnston S. Sheng A. El-Naggar M.C. Hung High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma Oncogene 19 2000 2398-2403
20. S. Yamamoto Y. Tomita Y. Hoshida et al. Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis Clin. Cancer Res. 10 2004 651-657
21. H. Yang Z. Filipovic D. Brown S.N. Breit L.T. Vassilev Macrophage inhibitory cytokine-1: A novel biomarker for p53 pathway activation Mol. Cancer Ther. 2 2003 1023-1029
22. M. Zhang N. Maass D. Magit R. Sager Transactivation through ETS and Ap1 transcriptional sites determines the expression of the tumor-suppressing gene maspin Cell Growth Diff. 8 1997 179-186
23. M. Zhang S. Sheng N. Maass R. Sager Maspin: The mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility Mol. Med. 3 1997 49-59
24. M. Zhang O. Volpert Y.H. Shi N. Bouck Maspin is an angiogenesis inhibitor Nature Med. 2 2000 196-199
25. W. Zhang M. Zhang Tissue microarray analysis of maspin expression and its reverse correlation with mutant p53 in various tumors Int. J. Oncol. 20 2002 1145-1150
26. Z. Zou A. Anisowicz M.J. Hendrix et al. Maspin a serpin with tumor-suppressing activity in human mammary epithelial cells Science 263 1994 526-529
27. Z. Zou C. Gao A.K. Nagaich T. Connell S. Saito J.W. Moul P. Seth E. Appella S. Srivastava p53 regulates the expression of the tumor suppressor gene maspin J. Biol. Chem. 275 2000 6051-6054